ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) currently has a daily average trading volume of 2.25M but it saw 5238743 shares traded in last market. With a market cap of 105.71M USD, the company’s current market price of $2.31 came rising about 26.92 while comparing to the previous closing price of $1.82. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.32 and as low as $0.27. In the recent trading on the day, stock has struck highest price mark of $1.87 while lowest mark touched by it was $2.33.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on December 02, 2022, recommending a price target of $9 for it.
Over the week, IPA’s stock price is moving 32.76% up while it is 145.74% when we observe its performance for the past one month. Year-to-date it is 171.76% up and over the past year, the stock is showing an upside performance of 461.09%.
The company is expected to be releasing its next quarterly report on 2025-Mar-28, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $6.4M as analysts are expecting the sales for current fiscal year at $25.43M and seeing the company making $29M in sales next year. Moreover, analysts are in estimates of $7.89M for current-quarter revenue.
Currently, ImmunoPrecise Antibodies Ltd’s total number of outstanding shares is 45.77M with 5.21% of that held by the insiders while 8.65% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -132.36% and return on equity (ROE) at -121.65%. Stock’s beta reads 0.57. Stock has a price to book (P/B) ratio of 6.09 while price to sale or P/S ratio amounts to 6.07. Its return on asset (ROA) is -73.58% on average.
